Director's Message

SingHealth Duke-NUS Institute of Precision Medicine (PRISM) is the flagship Joint Research Institute dedicated to pioneering advances in the integration of genomics with detailed medical phenotypes for translational research and discovery. PRISM also leads clinical implementation and adoption of genomics through testbed clinics for both patients and healthy individuals.

At PRISM, our mission is to translate cutting-edge research into actionable insights that enhance personalized patient care and improve outcomes for individuals and their families. We believe that each individual is unique and would benefit from precision medicine, wherein the intricacies of an individual’s genetic makeup, environment, and lifestyle are leveraged to optimize therapeutic outcomes. A key underpinning of precision medicine is data – data about you and how you have responded to treatments in the past. By harnessing the power of genomic sequencing and integrating diverse datasets encompassing genetics, lifestyle, and clinical information, we endeavour to develop predictive tools that empower healthcare professionals to deliver cost effective personalized interventions to improve the overall health and well-being of all Singaporeans.

To achieve this mission, we collaborate closely with partners within the SingHealth, Duke-NUS, and A*STAR community to drive innovation and accelerate the pace of discovery. Through initiatives such as PRECISE SG100K and SUNRISE, we are also engaging the Singaporean community to facilitate population-based genomic research in groups that have been historically underrepresented.

Please join us on this transformative journey as we strive to shape the future of healthcare in Singapore and beyond. Together, let us unlock the potential of precision medicine to deliver person-centred care and improve health outcomes for all Singaporeans.

Dr Saumya Jamuar

Director, PRISM